Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to evaluate the effect of Aquamin F versus placebo on NSAID
(non-steroidal anti-inflammatory drug) dose reduction in subjects with osteoarthritis of the
knee.
Hypothesis 1: After 12 weeks of treatment, subjects taking Aquamin F will use significantly
less NSAID medications for symptoms of osteoarthritis versus placebo alone.
Hypothesis 2: No significant differences will be seen for adverse events between the subjects
taking Aquamin F or placebo.